/ Culture - Education and Public Health
Surprising Effects, Remarkable Treatment Method
  Medical workers in the Democratic People's Republic of Korea are supporting the public health policy of the Workers' Party of Korea with all their wisdom and passion. Among them are those of the Stellate Ganglion Block Department of the Moranbong District Hospital in Pyongyang.



  They produce surprising curative effects by applying new non-hormone therapy called stellate ganglion block without using hormone drugs which cause some side effects in the treatment of diseases due to female hormone dysfunction.
  "I'm Paek Son Hae living in Chonghwa-dong No. 1, Hwasong District of Pyongyang.
  I started to receive this treatment here in February 2017. After three months, the bleeding stopped and other women's diseases gradually disappeared. I received the treatment for 15 days every month and people say I look vital, vigorous and beautiful."
  It is a general view of the world medical circles that stellate ganglion block therapy is effective for killing pains in the domain governed by stellate ganglion and for curing diseases due to autonomic nervous system disorder.
  The medical workers of the department have made persistent and persevering efforts to widely introduce the stellate ganglion block therapy into clinical practice for over 10 years on the basis of the profound theoretical development and elucidation of the field of stellate ganglion. In the course, they developed a treatment method based on stellate ganglion block therapy which can be one of the main methods for curing female hormone diseases, and enriched its effectiveness.



  Kim Chol Ung, Head of the Stellate Ganglion Block Department, says:
  "We will complete the Korean-style method of curing female hormone diseases on a higher level, aware of our mission that we are responsible for the health and lives of our people valued most by the Party, and thus add glory to the superiority of our socialist public health system."
  Now the treatment of female hormone diseases based on the stellate ganglion block therapy attracts the attention of the public health sector.